Home・Lista de Ações・Elanco Animal Health Inc

Elanco Animal Health Inc

Abrir

SetorSaúde

25.56 -0.47

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

25.26

Máximo

25.82

Indicadores-chave
By Trading Economics
Rendimento	289M 57M
Vendas	227M 1.4B
P/E Médio do Setor	372.714 64.641
EPS	0.4
Margem de lucro	4.158
Funcionários	9,400
EBITDA	310M 316M

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+17.19% upside

Dividendos
By Acuity
Próximos Ganhos	5 de ago. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	1.4B 13B
Abertura anterior	26.03
Fecho anterior	25.56

Sentimento de Notícias

By Acuity

40%

60%

128 / 340 Ranking em Healthcare

Elanco Animal Health Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

3 de ago. de 2026, 20:02 UTC

Elanco Animal Health is trading lower amid a broader market decline, reflecting negative sentiment in the pharmaceuticals sector. No specific news was identified.

31 de jul. de 2026, 23:01 UTC

Elanco Animal Health Inc shares are lower in after-market hours, trading near the lower end of their one-month range with no specific news identified.

30 de jul. de 2026, 16:11 UTC

Elanco Animal Health is lower today, influenced by declines in the Pharmaceuticals sub-sector. The stock remains above its 20-day moving average.

29 de jul. de 2026, 18:14 UTC

Elanco Animal Health shares are higher today, breaking a pattern of recent daily closes. No specific news was identified to explain the movement.

28 de jul. de 2026, 18:26 UTC

Correlated Moves

News

Bank of America maintains its buy rating on Elanco Animal Health, citing a favorable catalyst profile ahead of second-quarter earnings. Shares are higher today.

27 de jul. de 2026, 18:36 UTC

Elanco Animal Health is trading higher, reflecting positive market conditions, though no specific news was identified to explain the price movement.

24 de jul. de 2026, 19:26 UTC

Elanco Animal Health shares are higher, reflecting broader market dynamics amid a pullback in crude oil prices and easing energy-related pressures.

23 de jul. de 2026, 10:16 UTC

Elanco Animal Health is trading roughly flat in pre-market hours, despite broader market declines influenced by earnings reports and rising oil prices.

22 de jul. de 2026, 19:25 UTC

News

Elanco Animal Health trades higher as Morgan Stanley raises price target to $26. New data shows Credelio Quattro effectively kills ticks faster than competitors.

21 de jul. de 2026, 19:26 UTC

Elanco Animal Health shares are higher, continuing a positive trend since Monday. Broader market optimism follows strong earnings from General Motors and Novartis.

20 de jul. de 2026, 19:46 UTC

Elanco Animal Health Inc. shares are lower today, continuing a decline since Friday's close, despite an earlier peak in the session.

Comparação entre Pares

Variação de preço

Elanco Animal Health Inc Previsão

Preço-alvo

By TipRanks

17.19% parte superior

Previsão para 12 meses

Média 30.14 USD 17.19%

Máximo 32 USD

Mínimo 26 USD

Com base em 11 analistas de Wall Street que oferecem metas de preço de 12 meses para Elanco Animal Health Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

11 ratings

Comprar

Manter

Vender

Com base em 11 analistas que deram avaliações de ações para Elanco Animal Health Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

128 / 340 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.